These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13123)

  • 41. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological comparison of a type sat 2 foot-and-mouth disease virus isolate from Sudan with other type SAT 2 strains.
    Abu Elzein EM; Crowther JR
    Bull Anim Health Prod Afr; 1979 Dec; 27(4):245-8. PubMed ID: 232850
    [No Abstract]   [Full Text] [Related]  

  • 43. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
    Morgan DO; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
    [No Abstract]   [Full Text] [Related]  

  • 44. [Formation of immunity in sheep inoculated with varying doses of the foot-and-mouth disease virus 0194].
    Rakhmanin PP; Alekhin RM; Darda PN; Kruglikov BA; Antoniuk VP
    Veterinariia; 1979 Jan; (1):32-3. PubMed ID: 217141
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
    Meloen RH; Briaire J
    J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzyme-labelled immunosorbent assay techniques in foot-and-mouth disease virus research.
    Abu Elzein EM; Crowther JR
    J Hyg (Lond); 1978 Jun; 80(3):391-9. PubMed ID: 206625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sub-type classification of strains of foot-and-mouth disease virus.
    Forman AJ
    J Hyg (Lond); 1975 Apr; 74(2):227-32. PubMed ID: 164501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross reactions of normal bovine sera with foot-and-mouth disease virus: incidence, duration, and effect of shipping stress.
    Andersen AA
    Am J Vet Res; 1978 Apr; 39(4):603-6. PubMed ID: 206170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of anti-idiotypic antibodies generated against foot-and-mouth disease virus neutralizing monoclonal antibodies.
    Baxt B; Garmendia AE; Morgan DO
    Viral Immunol; 1989; 2(2):103-13. PubMed ID: 2550021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype.
    Hernández J; Martínez MA; Rocha E; Domingo E; Mateu MG
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():213-6. PubMed ID: 1370534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum immunoglobulins in white rats immunized with foot-and-mouth disease virus antigens.
    Borovik RV; Guryanov VA
    Acta Virol; 1973 Sep; 17(5):399-408. PubMed ID: 4148114
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions].
    Salajov EL; Antoniouk VP
    Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008
    [No Abstract]   [Full Text] [Related]  

  • 56. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Butchaiah G; Rao BU
    Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA; Pinto AA; Arruda NV; Koseki I; Abuhab TG; Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1979; 46(3-4):111-5. PubMed ID: 233417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of anti-foot-and-mouth disease antibodies by immunofluorescence].
    Kudriavtseva GA; Kudriavtsev NV
    Veterinariia; 1973 Sep; 9():36-8. PubMed ID: 4361328
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
    Bolwell C; Parry NR; Rowlands DJ
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemagglutination by type SAT 2 foot-and-mouth disease viruses.
    Booth JC; Pay TW
    J Gen Virol; 1973 Jun; 19(3):397-404. PubMed ID: 4353214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.